In the past two decades, about 25% of the total funds for malaria (∼US$4 billion in 2023) has been historically donated by the USA.1 A reported US$68 million is indicated to have been spent on research and development of vector control strategies in 2023, with an emphasis on insecticide-treated nets (ITNs) and insecticidal products.1 As funding landscapes shift, malaria control programmes and their implementing partners must diversify strategies to sustain progress against the disease. The persistent transmission of malaria despite huge efforts to deliver timely case management and universal access to ITNs indicates that these core strategies might be reaching the limit of what they can achieve on their own, highlighting the need for complementary interventions.